메뉴 건너뛰기




Volumn 64, Issue 4, 2003, Pages 306-311

Phase II study of irinotecan and ifosfamide in patients with advanced non-small cell lung cancer

Author keywords

Chemotherapy; Ifosfamide; Irinotecan; Non small cell lung cancer; Phase II study

Indexed keywords

IFOSFAMIDE; IRINOTECAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

EID: 0038651272     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070286     Document Type: Article
Times cited : (5)

References (45)
  • 1
    • 0028843552 scopus 로고
    • Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
    • Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909.
    • (1995) BMJ , vol.311 , pp. 899-909
  • 3
    • 0022340594 scopus 로고
    • Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
    • Hsiang YH, Hertzberg R, Hecht S, Liu LF: Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Biol Chem 1985;260:14873-14878.
    • (1985) Biol Chem , vol.260 , pp. 14873-14878
    • Hsiang, Y.H.1    Hertzberg, R.2    Hecht, S.3    Liu, L.F.4
  • 4
    • 0023433855 scopus 로고
    • Supercoiling of the DNA template during transcription
    • Liu LF, Wang JC: Supercoiling of the DNA template during transcription. Proc Natl Acad Sci USA 1987;84:7024-7027.
    • (1987) Proc Natl Acad Sci USA , vol.84 , pp. 7024-7027
    • Liu, L.F.1    Wang, J.C.2
  • 11
    • 0030020182 scopus 로고    scopus 로고
    • Promising new agents in the treatment of non-small cell lung cancer
    • Edelmen MJ, Gandara DR: Promising new agents in the treatment of non-small cell lung cancer. Cancer Chemther Phamacol 1996;37:385-393.
    • (1996) Cancer Chemther Phamacol , vol.37 , pp. 385-393
    • Edelmen, M.J.1    Gandara, D.R.2
  • 12
    • 0030007671 scopus 로고    scopus 로고
    • Recent advances in the treatment of non-small cell lung cancer
    • Goss GD, Dahrouge S, Lochrin CA: Recent advances in the treatment of non-small cell lung cancer. Anti-Cancer Drugs 1996;7:363-385.
    • (1996) Anti-Cancer Drugs , vol.7 , pp. 363-385
    • Goss, G.D.1    Dahrouge, S.2    Lochrin, C.A.3
  • 13
    • 0342600736 scopus 로고
    • Ifosfamide in the treatment of bronchial carcinoma
    • Drings P: Ifosfamide in the treatment of bronchial carcinoma. Contr Oncol 1987;26:294-318.
    • (1987) Contr Oncol , vol.26 , pp. 294-318
    • Drings, P.1
  • 14
    • 0024502276 scopus 로고
    • European experience with ifosfamide in non-small-cell lung cancer
    • Drings P: European experience with ifosfamide in non-small-cell lung cancer. Semin Oncol 1989;16(suppl 3):22-30.
    • (1989) Semin Oncol , vol.16 , Issue.SUPPL. 3 , pp. 22-30
    • Drings, P.1
  • 15
    • 0025892245 scopus 로고
    • Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 Leukemia
    • Furuta T, Yokokura T: Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 Leukemia (in Japanese). Gan To Kagaku Ryoho 1991;18:393-402.
    • (1991) Gan To Kagaku Ryoho , vol.18 , pp. 393-402
    • Furuta, T.1    Yokokura, T.2
  • 17
    • 0023864510 scopus 로고
    • Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo
    • Tsuruo T, Matsuzaki T, Matsushita M, Saito H, Yokokura T: Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo. Cancer Chemother Phamacol 1988;21:71-74.
    • (1988) Cancer Chemother Phamacol , vol.21 , pp. 71-74
    • Tsuruo, T.1    Matsuzaki, T.2    Matsushita, M.3    Saito, H.4    Yokokura, T.5
  • 26
    • 0030836373 scopus 로고    scopus 로고
    • Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology
    • Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16,1997 by the American Society of Clinical Oncology. J Clin Oncol 1997;15:2996-3018.
    • (1997) J Clin Oncol , vol.15 , pp. 2996-3018
  • 28
    • 0033950286 scopus 로고    scopus 로고
    • Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group Trial
    • Bonomi P, Kim KM, Fairclough D, Cella D, Kugler J, Rowinsky E, Jiroutek M, Johnson D: Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group Trial. J Clin Oncol 2000;18:623-631.
    • (2000) J Clin Oncol , vol.18 , pp. 623-631
    • Bonomi, P.1    Kim, K.M.2    Fairclough, D.3    Cella, D.4    Kugler, J.5    Rowinsky, E.6    Jiroutek, M.7    Johnson, D.8
  • 31
    • 0000437978 scopus 로고    scopus 로고
    • Randomized trial comparing cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) versus CPT-11 alone in advanced non-small cell lung cancer (NSCLC)
    • Masuda N, Fukuoka M, Negoro S, Takada Y, Sugiura T, Ohashi Y, Ariyoshi Y, Niitani H: Randomized trial comparing cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) versus CPT-11 alone in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1999;18:459a.
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Masuda, N.1    Fukuoka, M.2    Negoro, S.3    Takada, Y.4    Sugiura, T.5    Ohashi, Y.6    Ariyoshi, Y.7    Niitani, H.8
  • 32
    • 0000829637 scopus 로고    scopus 로고
    • Preliminary results of a randomized phase III trial of docetaxel (D) and cisplatin (P) versus vindesine (V) and P in stage IV non small cell lung cancer (NSCLC)
    • Kunitoh H, Watanabe K, Ohashi Y, Niitani H: Preliminary results of a randomized phase III trial of docetaxel (D) and cisplatin (P) versus vindesine (V) and P in stage IV non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2001;20:323a.
    • (2001) Proc Am Soc Clin Oncol , vol.20
    • Kunitoh, H.1    Watanabe, K.2    Ohashi, Y.3    Niitani, H.4
  • 35
    • 0035880703 scopus 로고    scopus 로고
    • Flexible chemotherapy regimen with gemicitabin and vinorelbine for metastatic nonsmall cell lung carcinoma: A phase II multicenter trial
    • Hirsh V, Langleben A, Ayoub J, Cormier Y, Pintos J, Iglesias JL: Flexible chemotherapy regimen with gemicitabin and vinorelbine for metastatic nonsmall cell lung carcinoma: A phase II multicenter trial. Cancer 2001;92:830-835.
    • (2001) Cancer , vol.92 , pp. 830-835
    • Hirsh, V.1    Langleben, A.2    Ayoub, J.3    Cormier, Y.4    Pintos, J.5    Iglesias, J.L.6
  • 42
    • 0031956320 scopus 로고    scopus 로고
    • Ifosfamide and paclitaxel combination fot the treatment of advanced non-small cell lung cancer
    • Shepherd FA, Eisenhauer E: Ifosfamide and paclitaxel combination fot the treatment of advanced non-small cell lung cancer. Semin Oncol 1998;25(suppl 2):2-7.
    • (1998) Semin Oncol , vol.25 , Issue.SUPPL. 2 , pp. 2-7
    • Shepherd, F.A.1    Eisenhauer, E.2
  • 43
    • 0032744521 scopus 로고    scopus 로고
    • Ifosfamide in non-small-cell lung cancer
    • Rosell R, Martin C, Balana C: Ifosfamide in non-small-cell lung cancer. Ann Oncol 1999;10(suppl 5):25-28.
    • (1999) Ann Oncol , vol.10 , Issue.SUPPL. 5 , pp. 25-28
    • Rosell, R.1    Martin, C.2    Balana, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.